AP file photo

The Senate finally found an easy health care bill. It approved a bill this afternoon, 94-1, to reauthorize the user fees that help fund the Food and Drug Administration, one of the last actions it's expected to take before leaving for the August recess. The bill will help the agency collect fees from the drug and medical device industries, one of the main sources of funding for its oversight of the medical products.

Fast track: To speed the path to President Trump's desk, the Senate passed the House version of the bill so the two chambers wouldn't have to work out a final version.

Drug prices: The bill would try to take on rising drug prices by speeding the reviews of new generic drugs where there's not a lot of competition. The FDA would have eight months to review those applications. It's intended to prevent a repeat of situations like the one with Martin Shkreli, the so-called "pharma bro," who raised the price of a drug used by AIDS and cancer patients from $13.50 a pill to $750.

Go deeper

GAO finds Chad Wolf, Ken Cuccinelli are ineligible for top DHS roles

Photo: CQ-Roll Call, Inc via Getty Images

Acting Homeland Security Secretary Chad Wolf and his acting deputy Ken Cuccinelli are ineligible to be serving in their positions, the Government Accountability Office (GAO) decided in a report released Friday.

Why it matters: While the finding has no immediate power, it could be important evidence in litigation over policies enacted under Wolf and Cuccinelli's leadership, said America's Voice's Ur Jaddou, who served as chief counsel to U.S. Citizenship and Immigration Services (USCIS) under President Obama.

The many divisions over Trump's methane rollback

Illustration: Rebecca Zisser/Axios

EPA's decision to cut regulation of methane is laying bare an oil-and-gas industry divide and setting the stage for political battles this fall and beyond.

Why it matters: Methane is an extremely powerful greenhouse gas and the industry is a key emissions source.

Kushner says Trump didn't promote false Kamala Harris birtherism theory

White House senior adviser Jared Kushner told "CBS This Morning" on Friday that he does not believe President Trump promoted a baseless claim that Sen. Kamala Harris is ineligible to be vice president.

Driving the news: During a press briefing on Thursday, Trump did not question the veracity of a Newsweek op-ed that inaccurately claimed Harris may be ineligible for the office due to her parents' naturalization status at the time of her birth. Harris is an American citizen and was born in Oakland, Calif.